Literature DB >> 9918485

Pharmacotherapy for obesity.

D F Williamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9918485     DOI： 10.1001/jama.281.3.278

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  The increasing necessity for market-based pharmaceutical prices.

Authors:  J E Calfee
Journal:  Pharmacoeconomics       Date:  2000       Impact factor: 4.981

2.  Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.

Authors:  P Little; C D Byrne
Journal:  BMJ       Date:  2001-03-24

Review 3.  The role of marketing in pharmaceutical research and development.

Authors:  John E Calfee
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study.

Authors:  Jean-Marc Dumonceau; Erik François; Axel Hittelet; Abdel Ilah Mehdi; Marie Barea; Jacques Deviere
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

5.  Treatment of obesity: need to focus on high risk abdominally obese patients.

Authors:  J P Després; I Lemieux; D Prud'homme
Journal:  BMJ       Date:  2001-03-24

6.  Effect of Roux-en-Y gastric bypass on satiety and food likes: the role of genetics.

Authors:  Richard C Thirlby; Frohar Bahiraei; Jim Randall; Adam Drewnoski
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

7.  Halting the obesity epidemic: a public health policy approach.

Authors:  M Nestle; M F Jacobson
Journal:  Public Health Rep       Date:  2000 Jan-Feb       Impact factor: 2.792
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.